Items tagged with Advocacy
Global health and human rights organizations denounce Trump Administration decision to pull commitments to WHO during COVID-19 crisis (post with simple image)
Cutting global health funding in the middle of a pandemic will only prolong the devastating loss of life and economic damage in the U.S. and across the world, and undermine the response to other infectious diseases, including HIV, TB, and hepatitis C.
Civil society call for equitable and affordable access to COVID-19 and related diagnostics (post with simple image)
Advocates call for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to testing.
RCC-THV: Call to action in response to COVID-19 (post with simple image)
RCC-THV is concerned with the safety and health conditions of people affected by HIV, TB and viral hepatitis during the COVID-19 pandemic.
Call to action: Overcoming key barriers to scale up TPT (post with simple image)
More investment and greater collective efforts needed now if global TB preventive treatment (TPT) targets are to be met.
UNAIDS urges governments to ensure that HIV service providers from community-led organizations are recognized as essential service providers in the context of COVID-19 (post with simple image)
Community-led health service delivery has become even more critical in the context of COVID-19, as the needs of marginalized community members and the burden on the health sector are increasing, making it vital that continued provision of HIV, TB and other health services is secured.
Sustain, Adapt, Protect: A Call to Action on HIV, TB and COVID-19 (post with simple image)
Organizations are invited to sign on to a Call to Action on HIV, TB and COVID-19 developed by Frontline AIDS, ARASA, Global Coalition of TB Activists and TBpeople, alongside community organizations.
Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)
120,707 people signed petitions urging the corporation to drop the price.
Treatment Action Group statement on bedaquiline unaffordability (post with simple image)
Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
Activating a human rights-based TB response (post with simple image)
A technical brief for policymakers and program implementers - a joint effort of the Global Coalition of TB Activists, the Stop TB Partnership and the Northwestern Pritzker School of Law.
Page 107 of 127 · Total posts: 0
←First 106 107 108 Last→